LEADER 02308nam  2200601Ia 450 
001 9910778642303321
005 20230331004931.0
010   $a1-280-21230-6
010   $a9786610212309
010   $a0-309-55570-1
010   $a0-585-02544-4
035   $a(CKB)111000211177036
035   $a(SSID)ssj0000262019
035   $a(PQKBManifestationID)12040807
035   $a(PQKBTitleCode)TC0000262019
035   $a(PQKBWorkID)10269301
035   $a(PQKB)11082086
035   $a(MiAaPQ)EBC3377020
035   $a(Au-PeEL)EBL3377020
035   $a(CaPaEBR)ebr10062963
035   $a(OCoLC)923267715
035   $a(EXLCZ)99111000211177036
100   $a19900723d1990      ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 02$aA study of the evolution, effectiveness, and financing of public and private drug treatment systems$b[electronic resource] /$fCommittee for the Substance Abuse Coverage Study, Division of Health Care Services, Institute of Medicine ; Dean R. Gerstein and Henrick J. Harwood, editors
210   $aWashington, D.C. $cNational Academy Press$d1990
215   $axx, 332 p. $cill
225 0 $aTreating drug problems ;$vv.1
300   $a"This study was supported by the National Institute on Drug Abuse, U.S. Department of Health and Human Services, under Contract No. 283-99-0009 (SA)/9D/--T.p. verso.
311   $a0-309-04285-2 
320   $aIncludes bibliographical references and index.
606   $aDrug abuse$xTreatment$xEconomic aspects$zUnited States
606   $aDrug abuse$xTreatment$xGovernment policy$zUnited States
606   $aDrug abuse$xTreatment$zUnited States
606   $aHealth insurance$zUnited States
615  0$aDrug abuse$xTreatment$xEconomic aspects
615  0$aDrug abuse$xTreatment$xGovernment policy
615  0$aDrug abuse$xTreatment
615  0$aHealth insurance
676   $a362.29/0973
701   $aGerstein$b Dean R$01503492
701   $aHarwood$b Henrick J$01096607
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910778642303321
996   $aA study of the evolution, effectiveness, and financing of public and private drug treatment systems$93753037
997   $aUNINA